Occurrence of NKX3.1 C154T polymorphism in men with and without prostate cancer and studies of its effect on protein function.

NKX3.1, a member of the NK class of homeodomain proteins, is expressed primarily in the adult prostate and has growth suppression and differentiating effects in prostate epithelial cells. A C-->T polymorphism at nucleotide 154 (NKX3.1 C154T) is present in approximately 11% of healthy men with equal distribution among whites and blacks. In a cohort of 1253 prostate cancer patients and age-matched controls, the presence of the polymorphism was associated with a 1.8-fold risk of having stage C or D prostate cancer or Gleason score > or =7 (confidence interval, 1.01-3.22). The NKX3.1 C154T polymorphism codes for a variant protein that contains an arginine-to-cysteine substitution at amino acid 52 (R52C) adjacent to a protein kinase C phosphorylation site at serine 48. Substitution of cysteine for arginine 52 or of alanine for serine 48 (S48A) reduced phosphorylation at serine 48 in vitro and in vivo. Phosphorylation of wild-type NKX3.1, but not of NKX3.1 R52C or NKX3.1 S48A, diminished binding in vitro to a high-affinity DNA binding sequence. NKX3.1 also serves as a transcriptional coactivator of serum response factor. Treatment of cells with 12-O-tetradecanoylphorbol-13-acetate to phosphorylate NKX3.1 had no effect on NKX3.1 coactivation of serum response factor. Neither the R52C nor the S48A substitution affected serum response factor coactivation by NKX3.1 We conclude that the polymorphic NKX3.1 allele codes for a variant protein with altered DNA binding activity that may affect prostate cancer risk.

[1]  H. Morgenstern,et al.  Epidemiologic Research: Principles and Quantitative Methods. , 1983 .

[2]  Siavash Ghaffari,et al.  A candidate prostate cancer susceptibility gene at chromosome 17p , 2001, Nature Genetics.

[3]  D. Tindall,et al.  Isolation and androgen regulation of the human homeobox cDNA, NKX3.1 , 1998, The Prostate.

[4]  E. Martín-Blanco,et al.  Phosphorylation of the Drosophila engrailed protein at a site outside its homeodomain enhances DNA binding , 1995, The Journal of Biological Chemistry.

[5]  E. Gelmann,et al.  DNA-binding sequence of the human prostate-specific homeodomain protein NKX3.1. , 2000, Nucleic acids research.

[6]  C. Missero,et al.  Multiple Ras Downstream Pathways Mediate Functional Repression of the Homeobox Gene Product TTF-1 , 2000, Molecular and Cellular Biology.

[7]  R. Schwartz,et al.  GATA-4 and Nkx-2.5 Coactivate Nkx-2 DNA Binding Targets: Role for Regulating Early Cardiac Gene Expression , 1998, Molecular and Cellular Biology.

[8]  J. Kaprio,et al.  Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. , 2000, The New England journal of medicine.

[9]  T H Beaty,et al.  Family history and the risk of prostate cancer , 1990, The Prostate.

[10]  E. Feuer,et al.  Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. , 1999, Journal of the National Cancer Institute.

[11]  W. Isaacs,et al.  Allelic loss of chromosomes 16q and 10q in human prostate cancer. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[12]  M. Pike,et al.  Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA , 1999, The Lancet.

[13]  S. Izumo,et al.  Identification of the In Vivo Casein Kinase II Phosphorylation Site within the Homeodomain of the Cardiac Tisue-Specifying Homeobox Gene Product Csx/Nkx2.5 , 1999, Molecular and Cellular Biology.

[14]  M. Arnone,et al.  Mapping and Functional Role of Phosphorylation Sites in the Thyroid Transcription Factor-1 (TTF-1) (*) , 1996, The Journal of Biological Chemistry.

[15]  Nikolaj Blom,et al.  PhosphoBase, a database of phosphorylation sites: release 2.0 , 1999, Nucleic Acids Res..

[16]  J. Whitsett,et al.  Protein Kinase A Activation of the Surfactant Protein B Gene Is Mediated by Phosphorylation of Thyroid Transcription Factor 1* , 1997, The Journal of Biological Chemistry.

[17]  F. Collins,et al.  Evidence for a prostate cancer susceptibility locus on the X chromosome. , 1998, Nature Genetics.

[18]  F. Mitelman,et al.  Multiple structural chromosome rearrangements, including del(7q) and del(10q), in an adenocarcinoma of the prostate. , 1988, Cancer genetics and cytogenetics.

[19]  M. Karin.  Signal transduction from the cell surface to the nucleus through the phosphorylation of transcription factors. , 1994, Current opinion in cell biology.

[20]  E. Feuer,et al.  Cancer surveillance series: interpreting trends in prostate cancer--part II: Cause of death misclassification and the recent rise and fall in prostate cancer mortality. , 1999, Journal of the National Cancer Institute.

[21]  O. Kallioniemi,et al.  Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression. , 2000, Cancer research.

[22]  Yongsok Kim,et al.  Homeodomain-interacting Protein Kinases, a Novel Family of Co-repressors for Homeodomain Transcription Factors* , 1998, The Journal of Biological Chemistry.

[23]  H. Arnold,et al.  Targeted disruption of the Nkx3.1 gene in mice results in morphogenetic defects of minor salivary glands: parallels to glandular duct morphogenesis in prostate , 2000, Mechanisms of Development.

[24]  J. Hanley,et al.  Competing Risk Analysis of Men Aged 55 to 74 Years at Diagnosis Managed Conservatively for Clinically Localized Prostate Cancer , 1998 .

[25]  O. Bratt.  Hereditary prostate cancer , 2000, BJU international.

[26]  J. Manley,et al.  Allosteric regulation of even-skipped repression activity by phosphorylation. , 1999, Molecular cell.

[27]  P. Greengard,et al.  Protein Tyrosine Kinase Activity and Its Endogenous Substrates in Rat Brain: A Subcellular and Regional Survey , 1988, Journal of neurochemistry.

[28]  D. Morton,et al.  Loss of heterozygosity of the retinoblastoma and adenomatous polyposis susceptibility gene loci and in chromosomes 10p, 10q and 16q in human prostate cancer. , 1994, British journal of urology.

[29]  R. Schwartz,et al.  The Smooth Muscle γ-Actin Gene Promoter Is a Molecular Target for the Mouse bagpipe Homologue, mNkx3-1, and Serum Response Factor* , 2000, The Journal of Biological Chemistry.

[30]  P. Berggren,et al.  Identification of a nuclear localization signal, RRMKWKK, in the homeodomain transcription factor PDX‐1 , 1999, FEBS letters.

[31]  T. Rebbeck,et al.  GLUTATHIONE-S-TRANSFERASE (GSTM1) AND (GSTT1) GENOTYPE IN THE ETIOLOGY OF PROSTATE CANCER , 1999 .

[32]  Anindya Dutta,et al.  Phosphorylation of serum response factor, a factor that binds to the serum response element of the c-FOS enhancer. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[33]  K. Livak,et al.  Real time quantitative PCR. , 1996, Genome research.

[34]  J. Benichou,et al.  Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China. , 2000, Cancer research.

[35]  G. Coetzee,et al.  Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. , 1997, Journal of the National Cancer Institute.

[36]  D A Meyers,et al.  Major Susceptibility Locus for Prostate Cancer on Chromosome 1 Suggested by a Genome-Wide Search , 1996, Science.

[37]  P. Kantoff,et al.  The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[38]  Vitamin D receptor polymorphisms as markers in prostate cancer , 1999 .

[39]  M. Marberger,et al.  A polymorphism in the CYP17 gene is associated with prostate cancer risk , 2000, International journal of cancer.

[40]  J. Favaloro,et al.  Effect of the androgen receptor CAG repeat polymorphism on transcriptional activity: specificity in prostate and non-prostate cell lines. , 2000, Journal of molecular endocrinology.

[41]  T. Beaty,et al.  Hereditary prostate cancer: epidemiologic and clinical features. , 1993, The Journal of urology.

[42]  R. Schwartz,et al.  Recruitment of the tinman homolog Nkx-2.5 by serum response factor activates cardiac alpha-actin gene transcription , 1996, Molecular and cellular biology.

[43]  R. T. Curtis,et al.  A novel human prostate-specific, androgen-regulated homeobox gene (NKX3.1) that maps to 8p21, a region frequently deleted in prostate cancer. , 1997, Genomics.

[44]  R. Hayes,et al.  Sexual behaviour, STDs and risks for prostate cancer , 2000, British Journal of Cancer.

[45]  J. Mohler,et al.  Association of prostate cancer with vitamin D receptor gene polymorphism. , 1996, Cancer research.

[46]  M. Augustus,et al.  Coding region of NKX3.1, a prostate-specific homeobox gene on 8p21, is not mutated in human prostate cancers. , 1997, Cancer research.

[47]  M. Zannini,et al.  Identification of the Thyroid Transcription Factor-1 as a Target for Rat MST2 Kinase* , 1998, The Journal of Biological Chemistry.

[48]  M. Nirenberg,et al.  Drosophila NK-homeobox genes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[49]  R. Schwartz,et al.  Activation of the cardiac alpha-actin promoter depends upon serum response factor, Tinman homologue, Nkx-2.5, and intact serum response elements. , 1996, Developmental genetics.